Price
Target price
€210.60
€210.60
-1.500%
-3.2
-1.500%
€297.11
05.03.26 / Tradegate
WKN: 864330 / Symbol: WST / Name: West Pharmaceutical Services / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
West Pharmaceutical Services Inc. Stock
A loss of -1.500% shows a downward development for West Pharmaceutical Services Inc..
West Pharmaceutical Services Inc. is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
With a target price of 297 € there is a positive potential of 41.03% for West Pharmaceutical Services Inc. compared to the current price of 210.6 €.
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | -1.500% | 1.056% | 0.000% | -0.941% | -10.115% | -30.472% | -5.135% |
| Haemonetics Corp. | 0.910% | 7.619% | 1.802% | - | -17.518% | - | - |
| Bio-Rad Labs Inc. A | 0.790% | 1.840% | -8.537% | -3.647% | -9.849% | -49.741% | -51.360% |
| Neogen Corp. | -10.270% | -12.500% | -8.197% | -7.182% | 36.585% | - | - |
Comments
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for WST provided by MarketBeat